Urinary schistosomiasis transmission in Epe, an urban community of Southwest Nigeria

A Review of Nanomaterials and Microwave Synthesized Metal Oxides Nanoparticles in Schistosomiasis Diagnosis

Point of Care (POC) diagnosis provides an effective approach for controlling and managing Neglected Tropical Diseases (NTDs). Electrochemical biosensors are well-suited for molecular diagnostics due to their high sensitivity, cost-effectiveness, and ease of integration into POC devices. Schistosomiasis is a prominent NTD highly prevalent in Africa, Asia, and Latin America, with significant socioeconomic implications such as discrimination, reduced work capacity, or mortality, perpetuating the cycle of poverty in affected regions worldwide. This review explores recent advancements in nanoparticle-based electrochemical biosensors for disease diagnosis, specifically focusing on the schistosome parasite. The synthesis processes and advantages of microwave-assisted preparation of metal oxide nanoparticles are highlighted, showcasing improved purity and energy efficiency compared to traditional combustion methods. In detection prototypes, Schistosome Egg Antigen (SEA) derived from Schistosome mansoni eggs obtained from primary and secondary hosts were evaluated using direct Enzyme-Linked Immunosorbent Assay (ELISA) to measure antibody concentrations in the primary and secondary hosts post-injection. Biosensor system was then developed by modifying developed electrodes with Gold Nanopartcicles (AuNP), Aluminium Gallium Nitride/Gallium Nitride (AlGaN/GaN), Mercaptopropyltrimethoxysilane/Gold Nanoparticles (MPTS/AuNPs) or metal oxide nanoparticles in conjugation with schistosome antibodies, registering current response on interactions with SEA, via cyclic voltammetry (CV), differential pulse voltammetry (DPV), Electrochemical Impedance Spectroscopy (EIS), Amperometry (A) and other electrochemical techniques. This review provides a summary of various constructions of electrochemical biosensors for detecting schistosomiasis.

Human Schistosomiasis due to Schistosoma bovis in Nigeria

Schistosomiasis is a global public health challenge, especially in sub-Saharan Africa, where Nigeria has the highest burden of disease. Schistosoma hybrids have been discovered in various countries, including Nigeria, where livestock and human beings share common water resources. This study, carried out in three communities, two of which are endemic for urinary schistosomiasis, aimed to identify the urinary schistosomiasis causative agent by using a species-specific molecular technique and their evolutionary relationship. Polymerase chain reaction using primers specific for a partial DNA sequence of the mitochondrial cox1 gene of Schistosoma haematobium was carried out on pooled urine sediments preserved in 70% ethanol. DNA from the high-intensity pooled samples from Onye-Uku camp amplified, and a BLAST search identified the pooled samples as Schistosoma bovis, whereas S. haematobium DNA did not amplify. The phylogenetic relationship of the sequence showed that it clustered with an S. bovis hybrid obtained from a human host in Côte d'Ivoire and had close ancestry with isolates from cattle in Cameroon. This finding revealed the prevalence of S. bovis among some inhabitants in a zone in Nigeria where schistosomiasis is endemic.

Human schistosomiasis in Nigeria: present status, diagnosis, chemotherapy, and herbal medicines

Schistosomiasis is a neglected tropical disease caused by a parasitic, trematode blood fluke of the genus Schistosoma. With 20 million people infected, mostly due to Schistosoma haematobium, Nigeria has the highest burden of schistosomiasis in the world. We review the status of human schistosomiasis in Nigeria regarding its distribution, prevalence, diagnosis, prevention, orthodox and traditional treatments, as well as snail control strategies. Of the country's 36 states, the highest disease prevalence is found in Lagos State, but at a geo-political zonal level, the northwest is the most endemic. The predominantly used diagnostic techniques are based on microscopy. Other methods such as antibody-based serological assays and DNA detection methods are rarely employed. Possible biomarkers of disease have been identified in fecal and blood samples from patients. With respect to preventive chemotherapy, mass drug administration with praziquantel as well as individual studies with artemisinin or albendazole have been reported in 11 out of the 36 states with cure rates between 51.1 and 100%. Also, Nigerian medicinal plants have been traditionally used as anti-schistosomal agents or molluscicides, of which Tetrapleura tetraptera (Oshosho, aridan, Aidan fruit), Carica papaya (Gwanda, Ìbẹ́pẹ, Pawpaw), Borreria verticillata (Karya garma, Irawo-ile, African borreria), and Calliandra portoricensis (Tude, Oga, corpse awakener) are most common in the scientific literature. We conclude that the high endemicity of the disease in Nigeria is associated with the limited application of various diagnostic tools and preventive chemotherapy efforts as well as poor knowledge, attitudes, and practices (KAP). Nonetheless, the country could serve as a scientific base in the discovery of biomarkers, as well as novel plant-derived schistosomicides and molluscicides.

Epidemiological dynamics and associated risk factors of S. haematobium in humans and its snail vectors in Nigeria: a meta-analysis (1983-2018)

Schistosoma haematobium, a major pathogen of urogenital schistosomiasis, has been reported to be affecting an estimated 30 million people in Nigeria. Current national estimates of S. haematobium and its cercariae, in humans and snail vectors respectively, are lacking in Nigeria, hence systematic meta-analyses were conducted to understand the disease dynamics in the endemic country over a period of 35 years based on publications from five databases (AJOL, Ovid MEDLINE, Google Scholar, PubMed and Web of Science). The preferred reporting items for systematic reviews and meta-analyses (PRIMSA) checklist were used as the standard guide for the analyses. The prevalence of S. haematobium in human hosts in Nigeria using quality effects model was 32.1% (27.3-37.2), while schistosome cercariae were observed at 3.5% (0.0-11.9), 18.2% (4.7-36.8) and 18.7% (0.0-46.1) and for B. forskalii, Bulinus globosus and B. truncatus, respectively. The high report of schistosome cercariae indicates the continuous transmission of S. haematobium in humans especially with individuals who have frequent contact with freshwater. Heterogeneity of subgroup analyses (regions, zones, sex, age groups, diagnostic techniques) and risk factors (pathological signs, occupation, water sources, anthropogenic activities, treatment) were determined. The result showed prevalence of an endemic moderate class infection that has been linked to several risk factors. Therefore, there is need for increased awareness on the prevalence, transmission routes and treatment strategies to mitigate the disease in this endemic area.